tiprankstipranks
Advertisement
Advertisement

Life Science REIT Shareholders Back British Land Takeover Scheme

Story Highlights
  • Life Science REIT shareholders overwhelmingly approved British Land’s cash-and-share takeover scheme.
  • With key conditions met, the acquisition proceeds to court sanction, aiming for completion in April.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Life Science REIT Shareholders Back British Land Takeover Scheme

Claim 30% Off TipRanks

Life Science Reit Plc ( (GB:LABS) ) just unveiled an announcement.

Shareholders of Life Science REIT have overwhelmingly approved a recommended cash-and-share takeover by The British Land Company, voting in favour of a court-sanctioned scheme of arrangement. Both the Court Meeting and General Meeting saw more than 99% of votes cast by value backing the deal, including changes to the company’s articles needed to implement the transaction.

With these shareholder approvals secured, several key conditions to the acquisition have now been satisfied, and the deal moves to the final legal phase. Court sanction of the scheme is expected in mid-April, with completion targeted for later that month, after which shareholders should receive their cash and share consideration within 14 days, marking a significant consolidation move in the UK life sciences real estate market.

The most recent analyst rating on (GB:LABS) stock is a Hold with a £42.00 price target. To see the full list of analyst forecasts on Life Science Reit Plc stock, see the GB:LABS Stock Forecast page.

Spark’s Take on LABS Stock

According to Spark, TipRanks’ AI Analyst, LABS is a Neutral.

The overall stock score is primarily driven by significant financial instability and negative corporate events. The managed wind-down proposal and asset liquidation plan are major concerns, overshadowing any short-term technical strengths. The lack of profitability and negative valuation metrics further contribute to a low score.

To see Spark’s full report on LABS stock, click here.

More about Life Science Reit Plc

Life Science REIT plc is a UK-listed real estate investment trust focused on owning and managing life sciences and innovation-led properties. Its portfolio targets specialist laboratory, office and research space serving the life sciences sector, positioning the company within a niche but growing segment of the commercial property market.

Average Trading Volume: 4,810,343

Technical Sentiment Signal: Sell

Current Market Cap: £140.3M

See more insights into LABS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1